Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile: Industry Research Report

Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile

Published Date: October 2009

Published By: Datamonitor

Page Count: 113

Order Code: R313-55097

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Introduction

This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

Benchmark Chugai's performance against key rivals in the prescription pharmaceutical sector
Evaluate the impact of Chugai's alliance with Roche, including forecast strong growth for the Genentech-derived mAb portfolio in Japan
Assess the forecast performance of Actemra, the first monoclonal antibody product to be developed and successfully launched by a Japanese company

Please note: this is delivered as a Zip file.

Similar Products

• United States Type 2 Diabetes Market

Published Nov 2009 by Intellent

• Company Financials: Bayer AG

Published Nov 2009 by Datamonitor

• Thailand Pharmaceuticals and Healthcare Report Q1 2010

Published Nov 2009 by Business Monitor International

• Argentina Pharmaceuticals and Healthcare Report Q1 2010

Published Nov 2009 by Business Monitor International

• Takeda Pipeline, Products, Performance, Potential

Published Nov 2009 by Espicom Healthcare Intelligence